Europe Hemodialysis and Peritoneal Dialysis Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 Hemodialysis and Peritoneal Dialysis Market Size

• The global hemodialysis and peritoneal dialysis market size was valued at USD 28.51 billion in 2024 and is expected to reach USD 47.18 billion by 2032, at a CAGR of 6.50% during the forecast period
• This growth is driven by factors such as the rising prevalence of chronic kidney disease (CKD), increasing geriatric population, and growing adoption of advanced dialysis technologies across Europe

Hemodialysis and Peritoneal Dialysis Market Analysis

• Hemodialysis and peritoneal dialysis are life-sustaining treatments for patients with end-stage renal disease (ESRD), removing waste, toxins, and excess fluids from the blood when kidneys can no longer function properly
• The market growth is significantly driven by the increasing incidence of chronic kidney disease (CKD), aging population, and rising awareness about renal replacement therapies in Europe
• Germany is expected to dominate the Europe hemodialysis and peritoneal dialysis market with a market share of 23.5%, due to advanced healthcare infrastructure and increasing demand for eye surgeries
• France is expected to be the fastest growing country in the Europe hemodialysis and peritoneal dialysis market with 13.6% market share, supported by expanding healthcare access, modernization of dialysis infrastructure, and policy support for home dialysis adoption
• Hemodialysis machines segment is expected to dominate the market with a market share of 35.5% due to its critical role in renal replacement therapy and widespread use across both in-center and home dialysis settings

Report Scope and Europe Hemodialysis and Peritoneal Dialysis Market Segmentation       

Europe Hemodialysis and Peritoneal Dialysis Market Trends

“Technological Advancements and Home Dialysis Adoption”

• One prominent trend in the Europe hemodialysis and peritoneal dialysis market is the growing adoption of home dialysis solutions and the integration of advanced technologies in dialysis machines and consumables
• These innovations are enhancing patient autonomy and treatment efficiency by enabling remote monitoring, compact device designs, and AI-powered dialysis systems that optimize therapy delivery and reduce complications 
  • For instance, in the U.K. and France, healthcare systems are increasingly supporting home hemodialysis and peritoneal dialysis through reimbursement programs and digital health platforms, allowing better management of chronic kidney disease outside clinical settings
• These advancements are reshaping the dialysis landscape in Europe, improving patient quality of life, reducing the burden on hospitals, and driving demand for innovative, patient-centric dialysis solutions across the region

Europe Hemodialysis and Peritoneal Dialysis Market Dynamics

Driver

“Rising Burden of Chronic Kidney Disease (CKD) Across Europe”

• The increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) across European countries is a major factor driving demand for hemodialysis and peritoneal dialysis treatments
• Aging populations in countries such as Germany, Italy, and the U.K. are particularly affected, as elderly individuals are more susceptible to CKD due to associated comorbidities such as diabetes and hypertension
• As the number of patients requiring renal replacement therapy rises, there is a corresponding increase in demand for both in-center and home-based dialysis solutions across Europe

For instance,

• According to the European Renal Association (ERA), countries such as Spain and France have witnessed a steady increase in the number of dialysis patients over the past decade, with over 90,000 patients receiving dialysis treatment annually in Germany alone 
• The growing need for effective kidney care services and pressure on national healthcare systems is prompting the expansion of dialysis infrastructure, thereby boosting the demand for advanced dialysis equipment and consumables across the region

Opportunity

“Digital Health and Telemonitoring Expansion in Dialysis Care Across Europe”

• The integration of digital health technologies and telemonitoring solutions into dialysis care is creating new growth opportunities across the Europe hemodialysis and peritoneal dialysis market
• These advancements allow for remote patient monitoring, real-time data transmission, and personalized treatment adjustments, significantly improving outcomes, especially for home dialysis patients

For instance,

• In France and the Netherlands, national health systems are supporting digital transformation through funding initiatives and pilot programs that enable real-time tracking of dialysis parameters from home. This not only reduces the frequency of in-clinic visits but also helps healthcare providers manage complications more effectively 
• These innovations offer a promising opportunity to improve patient adherence, reduce hospitalization rates, and expand access to home-based dialysis, particularly for rural and aging populations across Europe

Restraint/Challenge

“High Infrastructure and Equipment Costs Limiting Adoption Across Europe”

• The high cost of establishing and maintaining dialysis infrastructure—including advanced dialysis machines, water treatment systems, and associated consumables—remains a significant barrier to widespread adoption across several European countries
• This financial burden is particularly challenging for public hospitals, rural healthcare facilities, and smaller dialysis centers operating under constrained budgets

For instance,

• In Eastern European countries such as Poland, Romania, and Hungary, limited healthcare funding and the high initial investment required for dialysis setups have delayed the modernization of treatment facilities and slowed the adoption of home dialysis options 
• Consequently, the financial strain associated with dialysis infrastructure continues to hinder market expansion and equitable access to advanced renal care across Europe

Europe Hemodialysis and Peritoneal Dialysis Market Scope

The market is segmented on the basis of hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products and services, peritoneal dialysis modality, disease indication, usage, and end user

In 2025, the hemodialysis machines is projected to dominate the market with a largest share in Haemodialysis product segment

The hemodialysis machines segment is expected to dominate the Europe hemodialysis and peritoneal dialysis market with the largest share of 35.5% in 2025 due to its critical role in renal replacement therapy and widespread use across both in-center and home dialysis settings. The segment benefits from technological advancements, such as automated controls, enhanced safety features, and improved patient monitoring, which increase treatment efficiency and outcomes. In addition, the growing prevalence of end-stage renal disease (ESRD) and rising preference for customized and portable dialysis solutions are fueling demand across the region

The synthetic dialyzers is expected to account for the largest share during the forecast period in dialyzers material type market

In 2025, the synthetic dialyzers segment is expected to dominate the market with the largest market share of 30.5%, due to their superior biocompatibility, higher efficiency in toxin removal, and reduced risk of allergic reactions compared to cellulose-based dialyzers. Their widespread adoption in chronic dialysis treatment and ongoing technological advancements further reinforce their leading position in the European market.

Europe Hemodialysis and Peritoneal Dialysis Market Regional Analysis

• Germany dominates the Europe hemodialysis and peritoneal dialysis market with a market share of estimated 23.5%, driven by its robust healthcare infrastructure, high prevalence of chronic kidney disease (CKD), and presence of major dialysis providers such as Fresenius Medical Care
• The growing investments in R&D and innovation by domestic players further contribute to Germany's leadership position, alongside increased utilization of home dialysis options supported by strong patient management programs
• France is expected to witness the highest growth rate in the Europe hemodialysis and peritoneal dialysis market with 13.6% market share, supported by expanding healthcare access, modernization of dialysis infrastructure, and policy support for home dialysis adoption
• The government’s strategic push towards cost-effective treatment and outpatient care is driving the transition from in-center to home-based dialysis

Europe Hemodialysis and Peritoneal Dialysis Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Fresenius Medical Care AG (Germany)
• B. Braun SE (Germany)
• Diaverum AB (Sweden)
• Nipro Europe Group Companies (Belgium)
• Medtronic (Ireland)
• EUROSETS (Italy)
• Hemotech (France)
• Vifor Pharma Management Ltd. (Switzerland)
• Hospal Industrie S.A.S. (France)
• Medica S.p.A. (Italy)
• Kawasumi Laboratories Europe GmbH (Germany)
• Dirinco B.V. (Netherlands)
• Toray Medical Europe GmbH (Germany)
• Nikkiso Europe GmbH (Germany)
• ELDORADO S.p.A. (Italy)
• Aferetica S.r.l. (Italy)
• Medisystem S.A. (France)

Latest Developments in Europe Hemodialysis and Peritoneal Dialysis Market

• In March 2025, Fresenius Medical Care expanded its home hemodialysis program across Germany and the U.K, offering upgraded portable dialysis machines and enhanced telemonitoring capabilities. This expansion aims to increase patient autonomy and reduce pressure on dialysis centers.
• In February 2025, B. Braun Avitum launched its Dialog iQ next-gen hemodialysis machine in Spain and Italy, integrating AI-based fluid balance adjustment, real-time treatment analytics, and better patient comfort features, supporting efficient and personalized care
• In January 2025, Diaverum introduced its d.HOLISTIC digital platform in clinics across France, Portugal, and Hungary. This platform enhances CKD management through predictive analytics, automated dialysis reporting, and personalized patient support tools
• In October 2024, Nipro Europe Group Companies announced the commercial availability of its Sureflux PES dialyzer range in Belgium and the Netherlands, offering improved biocompatibility and clearance performance, which supports better patient outcomes in long-term hemodialysis care
• In September 2024, Medtronic Europe launched a collaborative initiative with national health services in Sweden and Denmark to pilot automated peritoneal dialysis (APD) systems integrated with cloud-based monitoring, aimed at improving therapy compliance and reducing hospital readmissions 

SKU-18491